Eagle Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-195,449
| Closed | -$14.3M | – | 568 |
|
|
2024
Q1 | $14.3M | Sell |
195,449
-8,098
| -4% | -$591K | 0.07% | 235 |
|
|
2023
Q4 | $17M | Sell |
203,547
-193,223
| -49% | -$16.1M | 0.09% | 205 |
|
|
2023
Q3 | $11.7M | Sell |
396,770
-7,392
| -2% | -$218K | 0.07% | 234 |
|
|
2023
Q2 | $13.2M | Sell |
404,162
-96,223
| -19% | -$3.14M | 0.07% | 225 |
|
|
2023
Q1 | $17.6M | Sell |
500,385
-47,692
| -9% | -$1.68M | 0.1% | 179 |
|
|
2022
Q4 | $24.3M | Sell |
548,077
-10,673
| -2% | -$473K | 0.15% | 153 |
|
|
2022
Q3 | $27.1M | Buy |
558,750
+127,327
| +30% | +$6.17M | 0.18% | 146 |
|
|
2022
Q2 | $17M | Buy |
431,423
+196,878
| +84% | +$7.74M | 0.11% | 189 |
|
|
2022
Q1 | $8.63M | Buy |
+234,545
| New | +$8.63M | 0.04% | 298 |
|